搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Human Uncharacterized protein C4orf51 (C4orf51) CSB-YP512112HU
CSB-EP512112HU
CSB-BP512112HU
CSB-MP512112HU
CSB-EP512112HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative uncharacterized protein C12orf77 (C12orf77) CSB-YP512113HU
CSB-EP512113HU
CSB-BP512113HU
CSB-MP512113HU
CSB-EP512113HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Protein FAM195B (FAM195B) CSB-YP512114HU
CSB-EP512114HU
CSB-BP512114HU
CSB-MP512114HU
CSB-EP512114HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative uncharacterized protein C2orf90 (C2orf90) CSB-YP512115HU
CSB-EP512115HU
CSB-BP512115HU
CSB-MP512115HU
CSB-EP512115HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative aminoacrylate hydrolase RutD (rutD) CSB-YP512116ENN
CSB-EP512116ENN
CSB-BP512116ENN
CSB-MP512116ENN
CSB-EP512116ENN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus vulcanius 2-amino-5-formylamino-6-ribosylaminopyrimidin-4 (3H)-one 5'-monophosphate deformylase CSB-YP512117MRW
CSB-EP512117MRW
CSB-BP512117MRW
CSB-MP512117MRW
CSB-EP512117MRW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum Extracellular metalloprotease VDBG_01143 (VDBG_01143) CSB-YP512118VES
CSB-EP512118VES
CSB-BP512118VES
CSB-MP512118VES
CSB-EP512118VES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum High osmolarity signaling protein SHO1 (SHO1), partial CSB-YP512119VES1
CSB-EP512119VES1
CSB-BP512119VES1
CSB-MP512119VES1
CSB-EP512119VES1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum Probable Xaa-Pro aminopeptidase PEPP (PEPP), partial CSB-YP512120VES
CSB-EP512120VES
CSB-BP512120VES
CSB-MP512120VES
CSB-EP512120VES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum Vacuolar protein sorting/targeting protein 10 (VPS10), partial CSB-YP512121VES
CSB-EP512121VES
CSB-BP512121VES
CSB-MP512121VES
CSB-EP512121VES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum Probable zinc metalloprotease VDBG_09414 (VDBG_09414), partial CSB-YP512122VES
CSB-EP512122VES
CSB-BP512122VES
CSB-MP512122VES
CSB-EP512122VES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tityus discrepans Putative neurotoxin Na3 CSB-YP512123TOM
CSB-EP512123TOM
CSB-BP512123TOM
CSB-MP512123TOM
CSB-EP512123TOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Propionate kinase (tdcD) CSB-YP512124SXA
CSB-EP512124SXA
CSB-BP512124SXA
CSB-MP512124SXA
CSB-EP512124SXA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter turicensis DNA gyrase inhibitor (sbmC) CSB-YP512125DXZ
CSB-EP512125DXZ
CSB-BP512125DXZ
CSB-MP512125DXZ
CSB-EP512125DXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter turicensis Putative aminoacrylate hydrolase RutD (rutD) CSB-YP512126DXZ
CSB-EP512126DXZ
CSB-BP512126DXZ
CSB-MP512126DXZ
CSB-EP512126DXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 4-hydroxyphenylacetate decarboxylase activating enzyme (hpdA) CSB-YP512127DUP
CSB-EP512127DUP
CSB-BP512127DUP
CSB-MP512127DUP
CSB-EP512127DUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces scabies Pup--protein ligase (pafA) CSB-YP512128FOL
CSB-EP512128FOL
CSB-BP512128FOL
CSB-MP512128FOL
CSB-EP512128FOL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Trypanosoma brucei gambiense Flagellar attachment zone protein 1 (TbgDal_IV3690), partial CSB-YP512129TQW
CSB-EP512129TQW
CSB-BP512129TQW
CSB-MP512129TQW
CSB-EP512129TQW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia pyrifoliae Lipid A palmitoyltransferase PagP (pagP) CSB-YP512130EMZ
CSB-EP512130EMZ
CSB-BP512130EMZ
CSB-MP512130EMZ
CSB-EP512130EMZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Multidrug resistance protein MdtB (mdtB), partial CSB-YP512131YAU
CSB-EP512131YAU
CSB-BP512131YAU
CSB-MP512131YAU
CSB-EP512131YAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>